Sort by 
Astellas closes Seattle stem cell therapy site in cell and gene therapy consolidation
Japanese pharmaceutical company Astellas is closing its Seattle stem cell therapy site as part of a wider consolidation of its cell, gene therapy, and oncology research operations, affecting approximately 55 employees.
Boehringer Ingelheim opens London AI centre with £150m ten-year investment
German pharmaceutical company Boehringer Ingelheim is launching an artificial intelligence and machine learning centre in London, committing £150 million over ten years to accelerate pharmaceutical research and drug discovery capabilities.
Helus Pharma appoints Eric So as interim chief executive following Michael Cola departure
Clinical-stage pharmaceutical company Helus Pharma has appointed co-founder and Executive Chairman Eric So as Interim Chief Executive Officer following the immediate departure of Michael Cola, while a permanent successor search is under way.
Poolbeg Pharma secures MHRA authorisation for POLB 001 cancer immunotherapy trial
Irish clinical-stage biopharmaceutical company Poolbeg Pharma has received MHRA Clinical Trial Authorisation for its TOPICAL trial, with independent US payer research indicating multi-billion-dollar peak sales potential for lead candidate POLB 001.
From 18th to Front of the Field: Ireland’s Clinical Trials Reform Agenda Takes Shape
Ireland’s National Clinical Trials Oversight Group published a 20-recommendation reform roadmap in November 2025. The report positions Ireland to close the gap with EU peers and attract more pharmaceutical sponsors to Irish research centres.
LEP Biomedical Ltd wins Best Use of Technology Award at the Pharma Industry Awards 2025
Throwing it back to the Pharma Industry Awards 2025, LEP Biomedical Ltd claimed the Best Use of Technology Award for a pioneering application of 3D drug printing that delivered bespoke ocular drug delivery solutions with controllable mechanical properties and precision-managed drug release across multiple parameters. The win set a compelling benchmark for technology-driven pharmaceutical innovation in Ireland, raising the standard of real-world clinical impact and formulation ingenuity that entrants will look to match when the 2026 awards cycle opens.
AbbVie enters pain medicine space with up to $715 million Haisco licensing deal
US pharmaceutical giant AbbVie has entered a licensing deal with China's Haisco Pharmaceutical Group worth up to $715 million, marking the company's first move into new pain medicines as competition in the non-opioid pain space intensifies.
Novo Nordisk strikes US AI partnership with OpenAI to transform global drug discovery
Danish pharmaceutical giant Novo Nordisk has announced a strategic partnership with US-based OpenAI to embed artificial intelligence across its entire global operations, targeting full integration by the end of 2026 to accelerate drug discovery and manufacturing efficiency.
Alliance Pharmaceuticals names DEPT® as digital partner for UK and European portfolio
UK-based Alliance Pharmaceuticals has appointed global marketing and technology firm DEPT® as its end-to-end digital partner across the UK and Europe, covering creative, retail media management, and brand and performance media for its healthcare portfolio.
United Drug Wholesale rebrands Irish ostomy and urology unit as UroStomaCare
United Drug Wholesale has rebranded its Ostomy and Urology Care business unit as UroStomaCare, reinforcing its position as Ireland's leading provider of stoma and continence care products and services for pharmacy professionals and patients across Ireland.
Discover What's Happening
Explore our newsletters
Join our Newsletter to receive the latest industry trends, expert tips, and exclusive insights delivered straight to your inbox!
.png)
